Following last month’s post, We want new medicines but at what cost?, I thought we should follow up with an expert view on life for patients suffering from rare and genetic diseases.
We caught up with Nick Meade, from the Genetic Alliance UK, while he was in Brussels. We asked Nick why expensive research is carried out to develop cures for rare diseases affecting only a very small proportion of society.
Listen to his position and please comment.
Related News & Interviews: